NeuroPace Inc
NPCE· Nasdaq
Filed Mar 2, 2023 · 10-K · 61 days after period end · 0001528287-23-000007
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|
| Revenue | $12.79M | $11.00M | $10.75M |
| Net Income | -$11.15M | -$10.69M | -$4.62M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NeuroPace Inc · CIK 1528287 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 2, 2023 · 61 d after period end